Author

Emily L. Richardson

University of LeicesterORCID 0009-0006-3489-5182Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Andrew M. FryiD· 2 shared Laura O’ReganiD· 2 shared Axel KnebeliD· 1 shared Chang Gok Woo· 1 shared Dean A. Fennell· 1 shared Douglas J. LamontiD· 1 shared Giancarlo Barone· 1 shared Hui Jeong Jeong· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Andrew M. FryORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyScientific ReportsPeer-reviewedJan 27, 2026

NEK7 phosphorylation of cortactin modulates the migratory capacity of cells expressing EML4-ALK V3

Emily L. Richardson, Axel Knebel, Kees R. Straatman…·Andrew M. Fry

This study identifies NEK7-mediated phosphorylation of cortactin as a mechanism by which EML4-ALK V3 enhances cell migration through actin cytoskeleton remodeling.

DOI 10.1038/s41598-026-36484-4

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 4, 2019

EML4-ALK V3 drives cell migration through NEK9 and NEK7 kinases in non-small-cell lung cancer

Laura O’Regan, Giancarlo Barone, Rozita Adib…·Andrew M. Fry

The paper shows EML4-ALK V3 promotes cell migration via NEK9 and NEK7 kinases, leading to worse outcomes in lung cancer.

DOI 10.1101/567305

humanproteomics

𝕏 PostBluesky